The Bristol Cord Blood Bank was established as a pilot project within existing health services to establish costeffective recruitment, collection and processing suitable for use in the NHS should cord blood become a routine source of haemopoietic stem cells for transplantation in the UK. An important aim of the project was to evaluate the feasibility of establishing a midwifery-based collection network, thus utilising expertise already in place. Collection was performed on the delivery suite immediately after the placenta was delivered. The clinical experience of the midwife collector/counsellors allowed rapid pre-collection assessment of the condition of the cord and placenta. This prevented collection attempts from diseased or otherwise damaged placentas, leading to conservation of resources by preventing collection of most small volume donations. The bank was established within the National Blood Service, Bristol Centre to achieve Good Manufacturing Practice standards and ensure that processing was subject to the same stringency required for other sources of haemopoietic stem cells. Cord blood is an expensive resource. By utilising existing expertise in district Obstetric and National Blood Services, the Bristol Cord Blood Bank may serve as a model for health economic evaluation of cord blood banking of volunteer donations within the NHS. Bone Marrow Transplantation (2000) 25, 899-905.
Haemopoietic stem cells from human umbilical cord blood can be transplanted in place of bone marrow to treat children with leukaemia and other potentially fatal marrow diseases. [1] [2] [3] The future of cord blood as a practical source of haemopoietic stem cells for transplantation is uncertain and research is still ongoing. A cohort controlled study from the International Bone Marrow Transplant Registry comparing banked cord blood with bone marrow donations from registered unrelated volunteers is still awaited (John Wagner, . 4 Transplants performed worldwide show that low cell dose significantly decreases posttransplant survival. 4, 5 Therefore, to date, most cord blood transplant recipients have been small children under the age of 10 years.
The Bristol Cord Blood Bank (BCBB) was developed as a pilot research project to optimise recruitment, collection and processing of cord blood donations, with future incorporation of cord blood banking into the NHS in mind. An important aim of the project was to evaluate the feasibility of establishing a midwifery-based collection network, thus utilising expertise already in place within the NHS.
Establishment of the Bristol Cord Blood Bank

The district
The North Bristol NHS Trust provides community and hospital services to 500 000 people living in north Bristol and South Gloucestershire. Community midwives provide the majority of antenatal care in the community, with referral to the hospital antenatal assessment unit when necessary. During the 1997/1998 financial year there were 88 116 community midwife/patient visits compared with 16 000 maternity-related admissions to Southmead Hospital, which included 5500 births.
The National Blood Service, Bristol Centre, provides processing and storage facilities for bone marrow and peripheral blood stem cell harvests. The cord blood bank was established within this facility to achieve Good Manufacturing Practice (GMP) standards and ensure that processing was subject to the same stringency and underlying principles required for other sources of haemopoietic stem cells.
Staffing
Central Delivery Suite (CDS) at Southmead has a core staff of 40 full-time equivalent midwives working in shifts, as well as four teams of community midwives on rotational attachment.There was concern that if all midwives were asked to collect cord blood, there would have to be constant retraining in the collection procedures and an increased possibility of small volume collections and higher bacterial contamination rates, as the frequency of collections performed by any individual midwife would be low.
The collection system was therefore developed around senior core midwifery staff. Two senior midwives were seconded for 40% of their time to the cord blood bank as midwife counsellors. Their role was to organise the recruitment system, perform the collections, counsel and consent mothers for donation and organise the collection of maternal blood samples 6 months post partum for 'followup' virology screens. For the remaining 60% of their time they were midwives in charge of CDS. Cord blood banking was therefore seen by all staff as a development within midwifery services, not as an outside research project. With this arrangement it was possible to build up expertise and enthusiasm for the project within the obstetric department.
Recruitment
A two-stage recruitment and counselling procedure was developed within National Blood Service guidelines 6 anticipating a central role for the NBS should cord blood become a routine source of haemopoietic stem cells in the UK. Community midwives recruited healthy pregnant women during the third trimester by giving them information about the project and a leaflet highlighting lifestyle exclusion criteria. Certain aspects of the expectant mother's health and lifestyle are routinely discussed between the midwife and the mother to enable the best management of the pregnancy, delivery and immediate care of the newborn. Community midwives performed an initial 'pre-selection' and did not give the information to women whose known social history or personal and family medical history would warrant exclusion.
After reading the leaflets women either gave written consent for cord blood to be collected after delivery of the placenta, or were free to decline without giving a reason. Signed consent forms were placed in the mother's antenatal notes.
There were 8267 births on CDS between September 1997, when clinical cord blood collection commenced, and the end of the pilot research project in March 1999. In the first 6 months successful collections averaged 33% of those possible during the midwife counsellors' shifts (Table 1) . Improvements were made to the recruitment and collection procedures following an audit by the midwife counsellors in February 1998. These changes, combined with greater availability of processing facilities, enabled us to increase the collection rate to 53% for the following year.
Collection
Local hospital ethics committee approval was obtained for cord blood collection for clinical banking. Collections were made from normal deliveries, defined as gestation greater than 37 weeks, where the obstetric team was not aware of any potential complications.
The midwife in charge of the delivery informed one of the midwife counsellors if a mother had consented to cord blood collection and alerted them when delivery was imminent. The midwife delivered the baby and placenta, having been instructed not to alter the routine clinical management of the delivery because cord blood was being collected.
Collections were performed following the third stage of labour as previously described by the New York Cord Blood Bank. 7 Briefly, the obstetric team in charge of the delivery passed the placenta out of the delivery room to one of the midwife counsellors whose clinical experience allowed rapid pre-collection assessment of the condition of the cord and placenta. This assessment, which was based on the findings of a pre-clinical study, 8 took into account the size, health and condition of the placenta, the size of the infant, length of labour, and time of cord clamping. This prevented collection attempts from diseased or otherwise damaged placentas, leading to conservation of resources by preventing collection of most small volume donations.
The placenta was placed on a collection stand with the foetal surface positioned ventrally. The cord was cleaned with an alcohol spray. A venesection site was selected on the umbilical vein as near to the distal cord clamp as possible. The umbilical vein was cannulated with the needle of a standard Baxter Optipac triple blood collection pack (Baxter Healthcare Ltd, Newbury, UK); the volume of anticoagulant having been reduced to 23 ml for cord blood collection by the removal of 40 ml by sterile technique. The cord blood drained into the collection bag which was placed on a blood collection mixer (Baxter Optimix) throughout the collection to prevent clotting. The donation was labelled in the collection room with a maternal hospital label and placed in an insulated blood transport box on the delivery suite until collected for processing.
By the end of the research period, 749 donations had been collected for banking with a mean volume of 98 ml (s.d. 35), excluding the volume of anticoagulant. This compares favourably with other reports. In one study, collection by obstetricians during the third stage of labour was compared with collections by cord blood bank technicians after placental delivery. 9 The mean volume collected during the third stage of labour was 81 ml (n ϭ 293), and after placental delivery was 75 ml (n ϭ 41). In a smaller study of 42 collections, 10 a mean volume of 83 ml (s.d. 7.9) for 23 donations collected during the third stage compared with 48 ml (s.d. 4) for 19 donations collected after placental delivery. Therefore our decision to collect after placental delivery did not obviously compromise the volume of donations.
Four hundred and sixty-four donations were from vaginal deliveries, mean volume 92 ml (s.d. 32), and 285 after Caesarean sections, mean volume 107 ml (s.d. 36), P Ͻ 0.001. In the pre-clinical observational study 8 factors found to significantly enhance total nucleated count of the donation included the total volume collected. Therefore we used minimum volume as the most practical variable to decide whether a donation was suitable for clinical banking. Donations of less than 60 ml were excluded from the bank but, when applicable, were used for research. Of the 56 units discarded because they were below the defined minimum, 14 were after Caesarean deliveries, whilst 42 were post vaginal deliveries. These data indicate that donations collected after both vaginal and Caesarean deliveries are acceptable for clinical banking. However, if banking resources are limited, collection after delivery by Caesarean section should be chosen.
The pre-clinical study identified other clinical factors influencing the quality of donations. 8 Obstetric variables Targeted deliveries were the number of deliveries that occurred during the time that the midwife counsellors/collectors were on duty (08.00 to 16.00 Monday-Thursday during the study period).
found to be significantly associated with high total nucleated cell count (TNC) were long gestation, long labour and short time between delivery of the infant and cord clamping. The mean total TNC of the 614 banked buffy coat preparations was 10. Table 2 shows the post-volume reduction nucleated cell count on the 644 units processed to that stage, analysed with respect to parity. The mean cell count decreased from 11.18 ϫ 10 8 from primagravidae to 8.07 ϫ 10 8 from fifth parity deliveries. There is a significant difference between the nucleated cell count obtained from primiparous compared to multiparious mothers (P Ͻ 0.001). This observation may be due to the known association between shorter labour with increasing parity. Although these variables cannot be influenced, knowledge of their effect allows informed selection of 'best scenario' collections when banking resources are limited.
Overall 135 (18%) donations collected were discarded The mean TNC of donations obtained from primagravida was significantly higher than the mean TNC of donations from multiparous women, P Ͻ 0.001.
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for the reasons shown in Table 3 . This rate compares favourably with reports by other investigators. Data from Besançon gives an overall discard rate of 55%, 11 and from Milan 51%, 12 with 50% of the discards due to low volume. Cord blood banks in Mannheim 13 and Leuven 14 have reported discard rates due to low volume of 18% and 29%, respectively. The main reason for the low discard rate reported here is the pre-collection assessment of the placentas by the midwife collectors. This is an advantage over the practice of employing technical collection staff to work within the delivery ward 24 h a day collecting from all deliveries. This latter approach, which has been used in the New York and London Cord Blood Banks, may result in more collections, but wastes resources as more donations are discarded due to low volume. 15, 16 Another factor contributing to the low discard rate achieved by the BCBB was the pre-selection of volunteer mothers by community midwives collaborating in the pro- Table 3 Reason for discard of cord blood donations ject. Exclusions were based on standard life-style and family history criteria routinely obtained from mothers by community midwives to ensure the best possible management of the pregnancy, delivery and post-natal period.
Donor interview and maternal virological screening
If a successful collection was made, a midwife counsellor visited the mother soon after delivery to review and discuss her original consent for cord blood collection. The midwife counsellor administered a medical history questionnaire, compliant with the NBS Medical Assessment of Donors document 17 and, if there were no reasons why the collection should be excluded, ascertained if the mother was still willing to donate. A sample of maternal blood was then taken for the mandatory blood transfusion virological screens (HIV 1 and 2, HBsAg, HCV, CMV and syphilis). 6 Fortytwo units were discarded following the donor selection interview (Table 3 ) and eight following the results of the maternal blood tests.
There is still a debate in the cord blood banking community as to whether or not re-testing for viral markers at 6 months is practical. 18 In the system employed at the BCBB initial recall was by letter to the mothers. Seventynine percent returned samples taken at their doctor's surgery within 8 weeks (Table 4 ). The midwife counsellors telephoned those who had not responded by 8 weeks. As a result of proactive follow-up by the midwife counsellors, 91% of all samples requested were obtained and tested. If a second sample for virological screening had not been received 1 year after the original donation, the unit remained in the quarantine bank but could be made available for searches at the discretion of the requesting physician and the cord blood bank Medical Director.
Maternal consent
Written consent was obtained from the mother for the collected cord blood to be donated to the bank for clinical transplantation, research, or both. The donation was made on the understanding that the unit could not be reserved for family use. Consent included permission to contact the mother 6 months post partum for a repeat virological screen, and their GP to enquire about the child's general health.
Processing and microbiological screening of the cord blood units
Processing was performed within 24 h of collection of the cord blood. An aliquot was removed from each suitable donation for HLA typing, white blood cell count (WBC) and CD34-positive cell count to quality control the volume reduction procedure. Aerobic and anaerobic microbiological cultures were performed on all donations. Although the incidence of bacterial contamination was 16 out of 749 (2.3%), 11 were positive for coagulase-negative staphylococcus and the decision was taken to record their antibiotic sensitivities and bank the donations. Seven additional units were discarded as indicated in Table 3 .
Cord blood units were centrifuged to produce a buffy coat layer and the volume reduced to 30 ml using a Baxter Optipress II automated blood component extractor. 19, 20 A WBC and CD34 ϩ cell count were performed on every buffy coat fraction to assess the haemopoietic cell content of the processed donation.
Donations were cryopreserved in 6 ml of 50% DMSO in autologous plasma, to give a final concentration of 10% DMSO. The processed blood is placed in a 50 ml cryocyte 903 Table 4 Timing of receipt of maternal samples for repeat virology screens The table shows the number and percentage of samples returned within 8 weeks, within 12 weeks and those returned more than 3 months after they had been requested.
bag and frozen by controlled rate of Ϫ1°C/min down to Ϫ40°C followed by Ϫ5°C/min down to Ϫ160°C. This procedure was based on optimal cryopreservation protocols evaluated previously. 21 Units are stored in the vapour phase of liquid nitrogen and are available for bone marrow donor searches through the British Bone Marrow Registry once the 6 month maternal follow-up virological screens have been performed.
Future role of cord blood banking
Pilot data on unrelated cord blood transplants using volunteer donations have been published. 2, 4, 22 Results in small children with relatively good risk leukaemia are encouraging. 3, 23 In contrast, there are few data on unrelated cord blood transplants in adults because only 10-15% of cord blood donations contain sufficient TNC, CD34 ϩ cells and colony-forming cells for adult requirements. 8, 24 A recent review of the literature suggests that engraftment failure may be high after cord blood transplants in adults. 25 The BCBB was established with research funding utilising existing facilities and equipment. It also benefited from the enthusiasm generated within the community midwifery service by the midwife counsellors as all the recruitment of expectant mothers was performed voluntarily by the community midwives. Taking into account costs for staff, consumables and capital and revenue costs only on that equipment purchased specifically for the cord blood bank, the cost of banking one unit was £285 (Table 5) . It has been calculated that if the bank had been established as a stand-alone facility, the cost of banking one unit would have been approximately £500.
In the UK the four operational cord blood banks in Belfast, Bristol, London and Newcastle, operating within the Blood Transfusion Service, intend to maintain 20 000 stored unrelated donations between them. It is difficult to project the cost per unit supplied from the UK, as so far only a small number has been supplied, however, following FDA guidelines a charge of $15 300 (£10 000) is suggested. To recover costs of establishing the combined UK CBB, 26 Projected costs for provision of cord blood donations in the UK to transplant centres must be compared with £7000 to provide an unrelated marrow donation from the British Bone Marrow Registry, The Anthony Nolan Trust or the Welsh Registry. Cord blood is an expensive resource. Unrelated volunteer cord blood banking directed towards ethnic minority groups among whom there is a shortage of HLA-compatible unrelated volunteer marrow donors may, however, be a valuable cost effective initiative. 15, 27, 28 In summary, we have described a system for setting up and operating a district cord blood bank. We have utilised existing Obstetric and National Blood Service facilities and expertise. The Bristol Cord Blood Bank may serve as a model for health economic evaluation of cord blood banking of volunteer donations within the NHS.
